Don’t miss our top 5 cancer-related stories this month, including a guest commentary from an industry leader, our two-part series on trends in cancer research and more!
 
Revolutionizing and personalizing global health 
By E. Kevin Hrusovsky, PerkinElmer Inc.
As the complexity and volume of data continue to rise, bioinformatics is emerging as one of the cornerstones of personalized medicine, from enabling discovery and development of novel treatments and diagnostics to facilitating collection, analysis and interpretation of data that ultimately helps an individual patient.  

SPECIAL REPORT PART 1: ‘Good enough’ is no longer good enough
 
By Randall Willis, ddn Features Editor
Aiming beyond the standard of care in oncology  

SPECIAL REPORT PART 2: An aside on side effects 
By Randall Willis, ddn Features Editor
Are we really making things better for cancer patients?  

High-profile oncology partnership

By Jim Cirigliano, ddn Contributing Editor
Araxes Pharma and Janssen Biotech ink oncology drug development deal  

Natural neighbors
 
By Kelsey Kaustinen, ddn Features Editor
OSU, Biosortia link up to identify natural products for potential cancer treatments  

 

nanoString
 
To add your company or organization to our list, send an e-mail to editor@drugdiscoverynews.com.
 
 
PHARMAS & BIOTECHS
 
 
ACADEMIC/RESEARCH CENTERS
 
 
GROUPS & ORGANIZATIONS
 
 

BioSearch


Charles River Labs

eBiosciences

Tecan

ISSCR
CONTACT US
Drug Discovery News
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
New England Bio Labs
© Copyright 2013 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.